Cargando…

CD93 Correlates With Immune Infiltration and Impacts Patient Immunotherapy Efficacy: A Pan-Cancer Analysis

Background: The clinical implementation of immune-checkpoint inhibitors (ICIs) targeting CTLA4, PD-1, and PD-L1 has revolutionized the treatment of cancer. However, the majority of patients do not derive clinical benefit. Further development is needed to optimize the approach of ICI therapy. Immunot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zerui, Zheng, Mengli, Ding, Qiang, Liu, Mei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8886047/ https://www.ncbi.nlm.nih.gov/pubmed/35242761 http://dx.doi.org/10.3389/fcell.2022.817965

Ejemplares similares

Characterization of the Different Subtypes of Immune Cell Infiltration to Aid Immunotherapy
por: Li, Zhenqing, et al.
Publicado: (2022)

P4HA1, a Prognostic Biomarker that Correlates With Immune Infiltrates in Lung Adenocarcinoma and Pan-Cancer
por: Zhao, Qi, et al.
Publicado: (2021)

Immune Cell Infiltration Landscape of Ovarian Cancer to Identify Prognosis and Immunotherapy-Related Genes to Aid Immunotherapy
por: Li, Xiushen, et al.
Publicado: (2021)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Integrative Analysis of MUC4 to Prognosis and Immune Infiltration in Pan-Cancer: Friend or Foe?
por: Gao, Xiao-Peng, et al.
Publicado: (2021)

SNHG10 Is a Prognostic Biomarker Correlated With Immune Infiltrates in Prostate Cancer
por: Chen, Qiang, et al.
Publicado: (2021)

Pan-Cancer Study on Protein Kinase C Family as a Potential Biomarker for the Tumors Immune Landscape and the Response to Immunotherapy
por: Abdelatty, Alaa, et al.
Publicado: (2022)

ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer
por: Zhang, Junchang, et al.
Publicado: (2022)

The mutation in splicing factor genes correlates with unfavorable prognosis, genomic instability, anti-tumor immunosuppression and increased immunotherapy response in pan-cancer
por: Luo, Jiangti, et al.
Publicado: (2023)

Pan-cancer analysis of the angiotensin II receptor-associated protein as a prognostic and immunological gene predicting immunotherapy responses in pan-cancer
por: Hong, Kai, et al.
Publicado: (2022)

The Prognosis and Immune Checkpoint Blockade Efficacy Prediction of Tumor-Infiltrating Immune Cells in Lung Cancer
por: Liu, Xiangzheng, et al.
Publicado: (2021)

Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer
por: He, Lingling, et al.
Publicado: (2022)

The Pan-Cancer Crosstalk Between the EFNA Family and Tumor Microenvironment for Prognosis and Immunotherapy of Gastric Cancer
por: Xie, Rongrong, et al.
Publicado: (2022)

Mapk14 is a Prognostic Biomarker and Correlates with the Clinicopathological Features and Immune Infiltration of Colorectal Cancer
por: Wang, Dan, et al.
Publicado: (2022)

Identification of an Metabolic Related Risk Signature Predicts Prognosis in Cervical Cancer and Correlates With Immune Infiltration
por: Shang, Chunliang, et al.
Publicado: (2021)

Increased Nuclear Transporter Importin 7 Contributes to the Tumor Growth and Correlates With CD8 T Cell Infiltration in Cervical Cancer
por: Chen, Jing, et al.
Publicado: (2021)

Intra-Tumoral Delivery of IL-27 Using Adeno-Associated Virus Stimulates Anti-tumor Immunity and Enhances the Efficacy of Immunotherapy
por: Hu, Aiyan, et al.
Publicado: (2020)

Identification of an Autophagy-Related Risk Signature Correlates With Immunophenotype and Predicts Immune Checkpoint Blockade Efficacy of Neuroblastoma
por: Kang, Wenjuan, et al.
Publicado: (2021)

An integrated bioinformatic analysis of bulk and single-cell sequencing clarifies immune microenvironment and metabolic profiles of lung adenocarcinoma to predict immunotherapy efficacy
por: Li, Mengling, et al.
Publicado: (2023)

Ferroptosis-Related Gene MT1G as a Novel Biomarker Correlated With Prognosis and Immune Infiltration in Colorectal Cancer
por: Peng, Bi, et al.
Publicado: (2022)

Construction of a Promising Tumor-Infiltrating CD8+ T Cells Gene Signature to Improve Prediction of the Prognosis and Immune Response of Uveal Melanoma
por: Sun, Yifang, et al.
Publicado: (2021)

LCK and CD3E Orchestrate the Tumor Microenvironment and Promote Immunotherapy Response and Survival of Muscle-Invasive Bladder Cancer Patients
por: Zheng, Xiaonan, et al.
Publicado: (2021)

The Roles of Blood Lipid-Metabolism Genes in Immune Infiltration Could Promote the Development of IDD
por: Li, Weihang, et al.
Publicado: (2022)

Editorial: Tissue-resident immune cells in tumor immunity and immunotherapy
por: Del Prete, Annalisa, et al.
Publicado: (2022)

How the Discovery of the CD4/CD8-p56(lck) Complexes Changed Immunology and Immunotherapy
por: Rudd, Christopher E.
Publicado: (2021)

Identify the Prognostic and Immune Profile of VSIR in the Tumor Microenvironment: A Pan-Cancer Analysis
por: Liu, Yuanyuan, et al.
Publicado: (2022)

Comprehensive analysis of REST corepressors (RCORs) in pan-cancer
por: Zheng, Rong, et al.
Publicado: (2023)

Comprehensive Analysis of the Expression and Prognosis for ITGBs: Identification of ITGB5 as a Biomarker of Poor Prognosis and Correlated with Immune Infiltrates in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

The Pyroptosis-Related Signature Predicts Prognosis and Indicates Immune Microenvironment Infiltration in Gastric Cancer
por: Shao, Wei, et al.
Publicado: (2021)

AP3S1 is a Novel Prognostic Biomarker and Correlated With an Immunosuppressive Tumor Microenvironment in Pan-Cancer
por: Wu, Gujie, et al.
Publicado: (2022)

Immune Infiltration in Gastric Cancer Microenvironment and Its Clinical Significance
por: Zhang, An Zhi, et al.
Publicado: (2022)

Differential Role of PD-1 Expressed by Various Immune and Tumor Cells in the Tumor Immune Microenvironment: Expression, Function, Therapeutic Efficacy, and Resistance to Cancer Immunotherapy
por: Kim, Myeong Joon, et al.
Publicado: (2021)

Comprehensive Analysis Revealed that CDKN2A is a Biomarker for Immune Infiltrates in Multiple Cancers
por: Chen, Zheng, et al.
Publicado: (2021)

Pan-cancer and single-cell analysis reveal the prognostic value and immune response of NQO1
por: Shen, Liping, et al.
Publicado: (2023)

Identification of Immune Cell Infiltration Landscape and Their Prognostic Significance in Uveal Melanoma
por: Zhao, Han, et al.
Publicado: (2021)

Immune Cell Infiltration as Signatures for the Diagnosis and Prognosis of Malignant Gynecological Tumors
por: Liu, Qi-Fang, et al.
Publicado: (2021)

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
por: Xue, Shengbai, et al.
Publicado: (2022)

Identification of a Novel Immune Landscape Signature for Predicting Prognosis and Response of Endometrial Carcinoma to Immunotherapy and Chemotherapy
por: Liu, Jinhui, et al.
Publicado: (2021)

Association of Angiogenesis Gene Expression With Cancer Prognosis and Immunotherapy Efficacy
por: Li, Xin-yu, et al.
Publicado: (2022)

A Novel Immune-Related Prognostic Model for Response to Immunotherapy and Survival in Patients With Lung Adenocarcinoma
por: Zheng, Yujia, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_fnssvokv3tb94j9cvfju1eduot